OPKO Health, Inc. (NasdaqGS:OPK) announces a share repurchase program. Under the program, the company will repurchase up to $50 million worth of its shares from the purchasers of the 144A Notes. The purchase price per share of the common stock repurchased in such transactions will equal the closing sale price of the company?s common stock on January 4, 2024, which was $0.91 per share.

The company will use net proceeds from the offering of the 144A Notes to repurchase the shares.